Blueprint Medicines Corp [BPMC] posts $557.52M loss as revenue rises 13.30% to $204.04M
By USInMinutes
Published - Feb 16, 2023, 06:07 PM ET
Last Updated - Feb 19, 2023, 10:23 AM EST
Net Sales: | $204.04M |
Blueprint Medicines Corp [BPMC] posted a loss of $557.52M, marking a rise of 13.44% for this year.
Revenue rose to $204.04M this year compared to $180.08M in the previous year.
According to the latest annual report the company has filed with the SEC, current earnings were $-557.52M, up 13.44% from $-644.08M.
The company’s net sales for the period were $204.04M, up 13.30%. Net sales in the previous year were $180.08M.